randomized controlled trial
Latest
Leadership Support and Workplace Psychosocial Stressors
Research evidence indicates that psychosocial stressors such as work-life stress serves as a negative occupational exposure relating to poor health behaviors including smoking, poor food choices, low levels of exercise, and even decreased sleep time, as well as a number of chronic health outcomes. The association between work-life stress and adverse health behaviors and chronic health suggests that Occupational Health Psychology (OHP) interventions such as leadership support trainings may be helpful in mitigating effects of work-life stress and improving health, consistent with the Total Worker Health approach. This presentation will review workplace psychosocial stressors and leadership training approaches to reduces stress and improve health, highlighting a randomized controlled trial, the Military Employee Sleep and Health study.
Impact evaluation for COVID-19 non-pharmaceutical interventions: what is (un)knowable?
COVID-19 non-pharmaceutical intervention (NPI) policies have been one of the most important and contentious decisions of our time. Beyond even the "normal" inherent difficulties in impact evaluation with observational data, COVID-19 NPI policy evaluation is complicated by additional challenges related to infectious disease dynamics and lags, lack of direct observation of key outcomes, and a multiplicity of interventions occurring on an accelerated time scale. Randomized controlled trials also suffer from what is feasible and ethical to randomize as well as the sheer scale, scope, time, and resources required for an NPI trial to be informative (or at least not misinformative). In this talk, Dr. Haber will discuss the challenges in generating useful evidence for COVID-19 NPIs, the landscape of the literature, and highlight key controversies in several high profile studies over the course of the pandemic. Chasing after unknowables poses major problems for the metascience/replicability movement, institutional research science, and decision makers. If the only choices for informing an important topic are "weak study design" vs "do nothing," when is "do nothing" the best choice?
randomized controlled trial coverage
2 items
Explore how randomized controlled trial research is advancing inside Psychology.
Visit domain